Table 6.

Multivariate analysis including bax results

Endpoint	Variable#	Group	RR (95% CI)*	p-value†
LF	Bax	Positive	0.96 (0.48, 1.92)	0.90
	T-Stage	T3	0.98 (0.45, 2.13)	0.95
	GLSC	7–10	1.06 (0.50, 2.23)	0.87
	STAD	Yes	0.62 (0.30, 1.24)	0.18
DM	Bax	Positive	0.83 (0.47, 1.45)	0.51
	T-Stage	T3	0.95 (0.51, 1.78)	0.87
	GLSC	7–10	2.40 (1.17, 4.93)	0.02
	STAD	Yes	0.53 (0.30, 0.96)	0.03
CSM	Bax	Positive	1.09 (0.55, 2.17)	0.80
	T-Stage	T3	0.99 (0.45, 2.16)	0.98
	GLSC	7–10	1.93 (0.82, 4.57)	0.13
	STAD	Yes	0.71 (0.36, 1.41)	0.33

Abbreviations: LF = local failure; DM = distant metastasis; CSM = cause-specific mortality; GLSC = Gleason Score; STAD = short term androgen deprivation.

^*Relative risk (RR): a risk ratio of 1 indicates no difference between the two subgroups. The 95% confidence intervals are shown in parentheses.

^†p-value from Chi-square test using the Cox proportional hazards model.

^#All variables were dichotomous.